Literature DB >> 30963481

Developing pediatric three-dimensional upper airway normative values using fixed and interactive thresholds.

Ahmed I Masoud1,2, Farhan H Alwadei3, Abdurahman H Alwadei4, Edward Y Lin5, Maria Grace Costa Viana6, Budi Kusnoto6, Carla A Evans7.   

Abstract

OBJECTIVE: To develop and compare pediatric upper airway three-dimensional normative values using the two most commonly used cone beam computed tomography (CBCT) software: Invivo5 (fixed threshold) and Dolphin 3D (interactive threshold). STUDY
DESIGN: Out of 3738 CBCT scans, scans of 81 pediatric patients were utilized after applying strict exclusion criteria. The sample was grouped into two age groups (7-11 and 12-17 years). Intra-class correlation coefficient was used to test intra-rater and inter-rater reliability and showed coefficients greater than 0.9 indicating good reliability of the methods used.
RESULTS: Paired t tests showed that volumetric and area measurements obtained using Dolphin 3D were significantly larger than those obtained using Invivo5 (p < 0.05). The mean minimal cross-sectional areas (MCSA) for Dolphin 3D were 151 mm2 and 177 mm2 for age groups 1 and 2, respectively. The mean MCSA values for Invivo5 for age groups 1 and 2 were 120 mm2 and 145 mm2, respectively.
CONCLUSION: Pediatric upper airway volumetric, area, and linear measurements were reported after applying strict exclusion criteria including a validated sleep questionnaire. Our goal is that clinicians utilize the proposed-here normative values for screening and assist in the timely diagnosis and management of pediatric sleep apnea.

Entities:  

Keywords:  Adenoids; Airway; CBCT; OSA; Sleep apnea

Year:  2019        PMID: 30963481     DOI: 10.1007/s11282-019-00384-3

Source DB:  PubMed          Journal:  Oral Radiol        ISSN: 0911-6028            Impact factor:   1.852


  1 in total

1.  Anatomic development of the upper airway during the first five years of life: A three-dimensional imaging study.

Authors:  Ying Ji Chuang; Seong Jae Hwang; Kevin A Buhr; Courtney A Miller; Gregory D Avey; Brad H Story; Houri K Vorperian
Journal:  PLoS One       Date:  2022-03-11       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.